home / stock / wsnaf / wsnaf news


WSNAF News and Press, Wesana Health Holdings Inc Com From 05/31/22

Stock Information

Company Name: Wesana Health Holdings Inc Com
Stock Symbol: WSNAF
Market: OTC
Website: wesanahealth.com

Menu

WSNAF WSNAF Quote WSNAF Short WSNAF News WSNAF Articles WSNAF Message Board
Get WSNAF Alerts

News, Short Squeeze, Breakout and More Instantly...

WSNAF - WESANA HEALTH HLDGS reports Q1 results

WESANA HEALTH HLDGS press release (OTCQB:WSNAF): Q1 Record Q1 2022 operating results at Wesana Clinics. Opening of third Wesana Clinic in May 2022. For further details see: WESANA HEALTH HLDGS reports Q1 results

WSNAF - Wesana Announces First Quarter 2022 Financial Results

CHICAGO and TORONTO, May 31, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care para...

WSNAF - Wesana Health Outlines Accelerated Drug Development Pathway

CHICAGO and TORONTO, May 10, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care para...

WSNAF - Wesana Announces Singular Focus on Drug Development Prompting a Strategic Review of its Clinics and Other Care Delivery Assets

CHICAGO and TORONTO, May 05, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care para...

WSNAF - Wesana Health Holdings GAAP EPS of -$1.48, revenue of $0.27M

Wesana Health Holdings press release (OTCQB:WSNAF): FY GAAP EPS of -$1.48. Revenue of $0.27M (+800.0% Y/Y). For further details see: Wesana Health Holdings GAAP EPS of -$1.48, revenue of $0.27M

WSNAF - Wesana Health Reports Q4 2021 Financial Results and Provides Subsequent Period Highlights

CHICAGO and TORONTO, May 02, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care para...

WSNAF - Wesana Health (WSNAF) NobleCon18 Presentation Replay

Wesana Health (WSNAF) formal corporate presentation from NobleCon18 - Noble Capital Markets 18th Annual Small & Microcap Investor Conference - April 2022. Read More >>

WSNAF - KCSA Psychedelics Virtual Investor Conference Presentations Now Available for On-Demand Viewing

NEW YORK, April 29, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the April 27 th and 28 th KCSA Psychedelics Virtual Investor Conference are now available for on-demand viewing....

WSNAF - Wesana Health to Present Live at KCSA Virtual Investor Conference April 28th

CHICAGO and TORONTO, April 27, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care pa...

WSNAF - Wesana Is Exploring Broadening SANA-013 Lead Indication to Treat Major Depressive Disorder

Concurrently, the Company is launching a non-brokered private placement NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CHICAGO and TORONTO, April 18, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana&#...

Previous 10 Next 10